Published on 08 August 2023
Ethnic sensitivity assessments in biosimilar monoclonal antibodies clinical development programmes: necessary or not?
biosimilar development, ethnic sensitivity assessments, global access, monoclonal antibodies, multi-regional clinical trials, regulatory reforms
DOI: 10.5639/gabij.2023.1202.010
10.991 views